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Abstract
Purpose

The purpose of this work is to investigate the use of low‐energy monoenergetic decompositions obtained from
dual‐energy CT (DECT) to enhance image contrast and the detection of radiation‐induced changes of CT textures
in pancreatic cancer.

Methods

The DECT data acquired for 10 consecutive pancreatic cancer patients during routine nongated CT‐guided
radiation therapy (RT) using an in‐room CT (Definition AS Open, Siemens Healthcare, Malvern, PA) were
analyzed. With a sequential DE protocol, the scanner rapidly performs two helical acquisitions, the first at a tube
voltage of 80 kVp and the second at a tube voltage of 140 kVp. Virtual monoenergetic images across a range of
energies from 40 to 140 keV were reconstructed using an image‐based material decomposition. Intravenous (IV)
bolus‐free contrast enhancement in pancreas patient tumors was measured across a spectrum of monoenergies.
For treatment response assessment, the changes in CT histogram features (including mean CT number (MCTN),
entropy, kurtosis) in pancreas tumors were measured during treatment. The results from the monoenergetic
decompositions were compared to those obtained from the standard 120 kVp CT protocol for the same subjects.

Results

Data of monoenergetic decompositions of the 10 patients confirmed the expected enhancement of soft tissue
contrast as the energy is decreased. The changes in the selected CT histogram features in the pancreas during RT
delivery were amplified with the low‐energy monoenergetic decompositions, as compared to the changes
measured from the 120 kVp CTs. For the patients studied, the average reduction in the MCTN in pancreas from
the first to the last (the 28th) treatment fraction was 4.09 HU for the standard 120 kVp and 11.15 HU for the 40
keV monoenergetic decomposition.

Conclusions

Low‐energy monoenergetic decompositions from DECT substantially increase soft tissue contrast and increase
the magnitude of radiation‐induced changes in CT histogram textures during RT delivery for pancreatic cancer.
Therefore, quantitative DECT may assist the detection of early RT response.

1 Introduction
1.A. Theory

It is highly desirable to improve CT soft tissue contrast for radiation therapy (RT). The delineation of targets and
organs at risk (OAR) for treatment planning and delivery guidance could be improved by enhanced soft tissue
contrast. Furthermore, increased soft tissue contrast could potentially increase the sensitivity of CT for
treatment response. Contrast in CT depends on differences in the linear attenuation coefficient of the tissue

types being scanned, a quantity that is a function of x‐ray energy, electron density, and atomic composition.
Generally speaking, the lower the energy of the x ray, the larger the soft tissue contrast.
Dual‐Energy CT (DECT) is an emerging imaging technology in radiation oncology that utilizes the combination of
two different x‐ray spectra during image acquisition.1-3 Many approaches have been developed over the years,
including systems that use rapid voltage switching, two sources, layered detectors, splitting the x‐ray beam at
the source (using filtration), or acquiring images sequentially at different kV settings. Postprocessing of the
spectral information provides a wealth of clinically relevant information. The information can be used to
reconstruct virtual monoenergetic images that emphasize differences in material especially at lower keV
values.1
The virtual monoenergetic decomposition of DECT was described as early as 1976.2 The method typically
depends on basis material decomposition and the knowledge of the mass attenuation of the basis
materials.3 Virtual monoenergetic images (MEI) resemble a CT acquired at a single energy. Standard
polyenergetic CT images (PEI) are reconstructed from an x‐ray spectrum typically defined by the tube potential
(i.e., 120 kVp). These images average over the energy‐dependent differences in the linear attenuation. MEI can
enhance the image quality by exploiting the enhancement in contrast at x‐ray energies below 70 keV.
The energy dependence of the linear attenuation coefficients for monoenergetic x rays can be calculated from
formulae derived in a publication by Watanabe.4 The CT number (CTN) of a material in Hounsfield units (HU)
and the contrast are then calculated from the following formula where the linear attenuation coefficient, μ, is a
function of x‐ray energy:

𝐶𝐶𝐶𝐶𝐶𝐶 = 1000(
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Thus, we can calculate the expected CT contrast between materials A and B, as a function of x‐ray energy. In
𝐶𝐶𝐶𝐶𝐶𝐶𝐴𝐴 is the average CT number in a given uniform region of interest of material A. CT contrast is at a
Eq. 2, ������
maximum at the minimum achievable monoenergy, which is 40 keV for the DECT protocol applied. However, it is
known that noise also increases as the monoenergy decreases.5

1.B. Applications

The MEIs of DECT are the subject of numerous studies in diagnostic radiology, which typically use IV bolus. Yu et
al. reviewed clinical applications for beam‐hardening corrections, contrast and noise optimization, metal artifact
reduction, and material differentiation.3 Schneider et al. explored the enhanced contrast to noise ratio (CNR)
and vessel attenuation of cervical and cerebral DECT angiographic studies.6 Wichmann et al. reported an
enhanced CNR, subjective image quality, and tumor delineation of head and neck squamous cell
carcinoma.7 Sudarski et al. evaluated low‐energy MEI for enhanced CNR in abdominal and lower extremity
angiography.8 The following year Sudarski et al. evaluated subjective and objective image quality enhancements
for MEI of gastrointestinal stromal tumors.9 Kaup et al. found the optimal MEI energy level for subjective and
objective image quality of lung cancer lesions.10 Two studies (Frellessen et al. and Hardie et al.) demonstrated a
contrast enhancement for diagnostic pancreatic imaging.11, 12 Furthermore, it has been shown that
enhancements in CT image quality reduce uncertainties in patient positioning during image‐guided radiation

therapy (IGRT) and hence can reduce setup margins during treatment planning.13 It follows that contrast
enhancement from DECT would improve the quality of IGRT planning and delivery.
Beyond simply improving the image quality, low‐energy MEI could potentially improve the use of CT for
treatment response assessment due to its superior sensitivity to the change in material composition. It has been
reported that radiation can induce changes in CT texture features during RT of several cancers including
pancreas, head and neck, lung, and liver.14-17 Quantitative data extracted from daily CTs acquired during IGRT
using in‐room CT, such as changes in CT textures (histogram or higher order features) may be used to assess
radiation treatment response.14 However, CT‐based detection of the response depends on the image quality
(contrast, noise, spatial resolution). Lesions embedded in soft tissue, such as the pancreas, are difficult to detect
with CT because the soft tissue contrast is inadequate and hence the treatment response signal is relatively
small. On average a change in 4.7 HU on MCTN in the pancreas is reported between the first week and last week
of therapy based on conventional 120 kVp CTs, which is almost 10 times larger than the standard deviation of
the MCTN of water for this scanner.14 In comparison to traditional PEI CTs, we investigated how low x‐ray
energy MEI CT enhances the soft tissue contrast and thus amplifies the signal of radiation‐induced changes in CT
textures.
In this study, we first quantified the contrast enhancement of MEI/DECT based on patient data with pancreatic
cancers for low and high x‐ray monoenergies. Second, we investigated the enhancement of MEI/DECT on the
detection of treatment response during RT for pancreatic cancer based on quantitative analysis of daily DECTs.

2 Materials and methods
2.A. Hardware components

All CT data were acquired on a 64‐slice CT scanner (SOMATOM Definition AS Open; Siemens Medical Solutions
USA, Inc., Malvern, PA). The scanner was installed in a linac room on a sliding gantry (CT‐on‐rails). The standard
PEI scans were performed at a tube potential of 120 kVp, a pitch of 0.6, tube rotation time of 0.5 s, volume
computed CT dose index (CTDIvol) of 16.99 mGy, and a scan resolution of 0.98 × 0.98 mm in the scanning plane
with a 3‐mm slice thickness. Scan times vary from day to day and patient to patient based on the specific scan
length chosen from each day's topogram. The raw data were reconstructed using a medium sharp convolution
kernel (30f).
The DECT data were acquired on the same scanner using a sequential protocol known as Dual Spiral Dual
Energy. The protocol generated two CT datasets through successive helical scans at different kV and mA levels
(but the same tube rotation time, 0.5 s). The first and the second scan were at 80 kVp and 120 kVp with a pitch
of 0.6 and 1.2, respectively. The scan resolution was 0.98 × 0.98 mm with a 3‐mm slice thickness, equal to that
for the PEI. CARE Dose 4D (Siemens Healthcare) was used to reduce the dose to the patient. CARE Dose is an
automatic exposure‐control algorithm that modulates the tube current in the angular and longitudinal direction
based on the patient girth as measured in a topogram.18 Thus, the dose to the patients in the study varied but
the combined reference dose level was set equal to a standard abdominal CT (16.99 mGy). The reference dose
or “Reference mAs” is a parameter entered by the user to determine the desired level of image quality. It is an
effective mAs that produces the desired image quality on a standard sized patient. MEI reconstructions were
performed at the scanner using the built in MEI image‐based algorithm from 40 to 140 keV with a medium sharp
convolution kernel (30f) and an iterative reconstruction (SAFIRE strength 5; Siemens Healthcare) to reduce
noise, which increases as MEI energy decreases.5, 19 SAFIRE does not alter image contrast as has been
previously demonstrated on patient and phantom scans.20

2.B. Clinical data

The pancreatic cancer patients selected in this study were treated with preoperative RT of 50.4 Gy in 28 daily
fractions. The daily noncontrast standard CT or DECT was acquired at alternative fractions during the 6‐week RT
duration as a part of regular IGRT using the CT‐on‐rails system. The data for 10 consecutive patients with
respiration motion of pancreas head (as measured from a 4DCT acquired at simulation) less than 7 mm were
analyzed. The 7‐mm criterion is necessary because the sequential DECT protocol is not compatible with
respiration gating. For patients with more than 7 mm of target motion, gated IGRT is the standard of care in our
clinic. The DECT was scanned with the Dual Spiral Dual Energy protocol. MEIs were generated across a range of
x‐ray energies for comparison to the standard PEIs. In both image types, the targets and OAR were contoured
manually. If a stent was present in the bile duct for a pancreatic cancer case, it was delineated and excluded
from the analysis. Imaging contrast defined as the difference in CTN between the targets (pancreas head) and
OAR (duodenum) in both MEIs and PEIs acquired during consecutive IGRT fractions [see Eq. 2] was assessed
from the patient data.
In addition, the daily CT and DECT data were quantitatively analyzed to detect radiation‐induced changes of CT
histogram features in the target volume (e.g., pancreatic head). Treatment responses as evaluated through
changes in CT textures of the target for the MEIs and PEIs were compared. The change in MCTN of the aorta was
also assessed in these images in order to establish CTN stability. All contours were manually drawn by a single
physicist and checked with a radiation oncologist using a commercial tool (MIM version 6.4.5 (Build F204‐00),
MIM Software Inc., Cleveland, OH). The changes in the selected histogram features (MCTN, skewness, kurtosis,
entropy, standard deviation) were calculated for all 10 patients using an in‐house program developed in
MATLAB (version 2012b; MathWorks, Natick, MA). The histogram features evaluated are defined in the MATLAB
Statistics and Machine Learning Toolbox.

3 Results

From the selected patient data, we calculated the contrast [Eq. 2] between the pancreas head and the
duodenum which is shown in Fig. 1(a). The average contrast increases from 10.4 ± 7.9 to 24.6 ± 16.2 HU when
comparing the data from the 120 kVp images to those for the 40 keV images. This is an increase of 189%. The
reported uncertainty is the standard deviation of the calculated contrasts for all 10 patients. In Fig. 1, (b) and (c)
are axial slices from one of the selected patients [#9 in Fig. 1(a)] demonstrating the contrast enhancement when
comparing a 120 kVp PEI and a 40 keV MEI.

Figure 1 (a) The contrast (difference in mean CTN) between the pancreas and duodenum for the 10 patients in
the study measured at 120 kVp and 40 keV. (b) An axial slice of one of the patients scanned at 120 kVP. The
reconstruction kernel is 30f, the slice thickness is 3.0 mm, the pitch is 0.6, and the CTDIvol was 17 mGy. (c) An
axial slice of the same patient scanned with the Dual Spiral Dual Energy. The first scan is at 80 kVp with 3.0 mm
slice thickness and a pitch of 0.6. The second scan is at 140 kVp with 3.0 mm slice thickness and a 1.2 pitch. The
reconstruction kernel was 30f. The summed CTDIvol for both scans was 22 mGy. The W/L is 400/40 HU for (b)
and (c). [Color figure can be viewed at wileyonlinelibrary.com]

For one of the selected patients [#5 in Fig. 1(a)], a 40‐keV MEI axial slice from the first week (a) and last week (b)
are shown at the top of Fig. 2. The bottom two panels display 120 kVp PEI axial slices from the treatment days
immediately following the DECT scans (c and d). The magenta contour is the pancreatic head (the target) while
the light blue contour is the central 8 mm of the aorta. From the first week to the last week of treatment, the
MCTN in the pancreatic head dropped from 23.1 to 18.1 HU as measured in the 120 kVp PEIs, a ∆CTN of 4.9 HU.
However, for the same time period in the 40 keV MEI, the MCTN dropped from 39.8 to 24.5 HU, a ∆CTN of 15.3
HU. The CTN variance in the pancreatic head is of the order of 30 HU in a 120 kVp PEI and 50 HU in a 40 keV MEI
which is a reflection of the heterogeneity of pancreatic tissue. However, the mean value is quite stable. For
instance, in the aorta, outside of the radiation field, the MCTN only dropped by 0.1 HU in the 120 kVp images
and 1.0 HU in the 40 keV images.

Figure 2 (a) and (b) Axial slices of a patient scanned with the Dual Spiral Dual Energy protocol during the first and
last week of treatment. The first scan is at 80 kVp with 3.0 mm slice thickness and a pitch of 0.6. The second scan
is at 140 kVp with 3.0 mm slice thickness and a 1.2 pitch. The reconstruction kernel is 30f. The summed CTDIvol
for both scans is 22 mGy. The pancreas head is contoured in magenta and the center of the aorta is contoured in
light blue. (c) and (d) An axial slice of the same patient as in A&B scanned at 120 kVp. The reconstruction kernel
is 30f, slice thickness is 3.0 mm, pitch is 0.6, and the CTDIvol is 18 mGy. The W/L is 400/40 HU for (a–d). [Color
figure can be viewed at wileyonlinelibrary.com]
A bar graph of the change in mean CTN in the target of all the patients is shown in Fig. 3(a) along with the details
of each case in Fig. 3(b). For all cases we examined the magnitude of the change in mean CTN as measured in
the 40 keV MEI in comparison to the 120 kVp PEI. The average change in mean CTN was −11.1 HU for MEI,
whereas for PEI it was −4.1 HU. In the aorta, the mean CTN was stable; the average changes in the MEI and PEI
were −1.0 HU and −0.4 HU, respectively. Note that for one of the patients, the change in mean CTN in the
pancreas head is comparable to the change in the mean CTN outside of the treatment field (patient 4 in Fig. 3)
independent of whether the measurement is done with PEI or MEI. For this patient the pathological response
was graded a 2 (or partial response) on the Ryan scheme for tumor regression. Hence, MEI did not create a CT‐
based treatment response signal that was not evident in the PEI which is an essential feature of the treatment
response enhancement.

Figure 3 (a) The change in the mean CTN between the first and last week of treatment for the 10 pancreas
patients in the study as measured at 120 kVp and 40 keV. (b) A table summarizing the mean CTN change (HU) in
the target and aorta along with the target location for each patient. [Color figure can be viewed
at wileyonlinelibrary.com]
Figure 4 compares the changes in selected histogram features (mean CTN and normalized entropy) during
treatment for two patients between 120 kVp PEI and 40 keV MEI. The radiation‐induced changes in CT textures,
both magnitude and timing, are patient specific as indicated for the two patients in Fig. 4. For instance, the
changes in mean CTN for patients 7 and 8 are of the same order of magnitude, but for patient 7 the change is
roughly linear vs time, while for patient 8 the change occurs during a single week. Figure 5 is a plot of the change
in selected CT histogram features of the pancreas head for patient 7 as a function of treatment week. The five
features (skewness, kurtosis, entropy, standard deviation, and mean CTN) are normalized independently to their
values obtained from the pancreas head in the scan from the first week for 40 keV MEI and 120 kVp study sets.
Note that the change in entropy was the largest relative change among the selected histogram features.
Figure 6 compares the changes in entropy from the first week to last week of treatment for the 10 patients
between data from 40 keV MEI and 120 kVp PEI.

Figure 4 Changes in selected histogram features (mean CTN and normalized entropy) for two patients during
treatment for both 120 kVp PEI and 40 keV MEI. [Color figure can be viewed at wileyonlinelibrary.com]

Figure 5 The relative change in five first‐order texture features for pt 7 from 40 keV MEI and 120 kVp PEI as a
function of treatment week. [Color figure can be viewed at wileyonlinelibrary.com]

Figure 6 The change in histogram entropy for the 10 patients in the study from 40 keV MEI and 120 kVp PEI as a
function of treatment week. [Color figure can be viewed at wileyonlinelibrary.com]

4 Discussion
This study had two aims. First it sought to quantify the CT contrast enhancement available through the use of
DECT for pancreas cancer. Specifically, low‐energy MEI generated from a sequential DECT protocol feature
substantially increased soft tissue contrast relative to traditional PEIs. For radiation oncology applications such
as IGRT, relatively poor soft tissue contrast of conventional CT can lead to uncertainty in soft tissue‐based
registration. Improved image quality results in reduced uncertainty in soft tissue registration as described by
Morrow et al.13 CT‐based RT planning also depends on adequate soft tissue contrast to accurately delineate the
edge between targets and organs at risk. Secondly, it sought to measure the amplification of the CT texture‐
based treatment response signal during pancreatic cancer RT from low‐energy MEI relative to traditional PEI. As
reported previously, the radiation‐induced CT texture changes during chemo‐RT for pancreatic cancer correlated
with tumor pathological response, although the changes were generally small from the conventional 120 kVp
CTs.14 We seek to demonstrate that low‐energy MEI will increase the magnitude of the signal and thus make
the radiation‐induced changes in CT textures easier to detect during fractionated treatment. The determination
of a threshold in the signal that would motivate an adaptive therapy plan is beyond the scope of this exploratory
study but is a goal of future work.

The sequential MEI protocol used in this study does have limitations. Patient motion between the two
acquisitions of the sequential protocol can result in artifacts in the MEI. Furthermore, the Dual Spiral Dual
Energy sequential protocol was not compatible with respiratory‐gated CT scans. All the pancreatic patients in
this study had a tumor respiratory motion smaller than 7 mm as measured by 4DCT acquired at the time of
simulation. For patients with larger tumor respiratory motion, daily CT and treatment were gated in our
institution which precluded them from the benefit of the sequential DECT protocol. It is our finding that roughly
one‐third of our pancreas cancer patients require respiratory gating. There are typically two pancreatic cancer
patients treated on the linac with the DECT protocol at any given time in our clinic.
Dual Spiral Dual Energy protocol is designed to be dose neutral compared to the standard protocol 120 kVp for a
given patient. Radiation therapy patients, being treated for tumors in the pancreas head received doses of 50–
70 Gy. The patients received CT guidance at each fraction to assure their positioning accuracy. As a result, they
received an additional dose of radiation that increased their overall dose by roughly 0.5 Gy (18 mGy in 28
fractions), or less than 1% of their total dose. If one considers the integrated dose, our analysis indicates that the
IGRT dose is closer to 10% of the therapeutic dose; kV cone‐beam IGRT scans, which are more common, require
as much as 50% more dose than the CT‐on‐rails imaging used here. DECT protocols may expose the patients to
slightly elevated doses if their body width was larger than average. However, when these protocols are coupled
with dose reduction algorithms such as CARE dose 4D, the benefits of DECT are achievable with a dose increase
no more than 4 mGy per fraction employed. CARE dose 4D modulates the dose based on the patient width as
measured from the topogram. Larger than average patients will receive a slightly elevated dose so that noise is
reduced to a level that would be similar to patients of average diameter. Patients with smaller than average
abdomen diameters had their dose reduced due to the application of the dose reduction algorithm.18
For pancreatic cancer, treatment response was difficult to detect with standard CT because of the poor soft
tissue contrast. Soft tissue features of the glands and embedded tumor were nearly indistinguishable in 120 kVp
PEIs [see Fig. 1(b) and Figs. 2(c) and 2(d)]. These images depended on a spectrum of x‐ray energies which have
different scattering properties. Low‐energy MEI such as those generated from dual‐energy protocols benefitted
from the photoelectric effect, resulting in a much broader range of CT numbers. As the x‐ray energy is
decreased, the contrast in the resulting images rapidly increased, enabling a differentiation between soft tissue
types. Enhancing the contrast between soft tissues in a single scan, as demonstrated by Fig. 1, can also amplify
the detection of treatment response as measured from successive scans over the course of fractionated
treatment.
The RT‐related changes in the composition of the tumor and surrounding tissue are amplified as demonstrated
by increased changes in the MEI target textures relative to the same textural changes in PEI (see Fig. 5).
Histogram features can vary during fractionated treatment and have been correlated with histological outcome
for pancreas cancer patients.14 The amplification of this change for a single patient via low‐energy MEI is
immediately evident in Fig. 5, but correlating that to treatment response is beyond the scope of this study.
Weekly variation in a single histogram feature for a single patient may or may not be related to treatment
response, but our analysis demonstrates that the MEI of DECT augments those changes. Therefore, treatment
response would be easier to detect via the MEI of DECT.
Periodic DECT during fractionated treatment may enable the detection of response earlier than was previously
achievable from standard CT. Specifically for pancreas cancers, the response signal may be difficult to distinguish
from noise after the first few weeks of treatment using standard CT. The change in PEI CT intensity after
completing therapy is only expected to be on the order of 5 HU for pancreatic tumors.14 During early fractions,
the change would be expected to be even less than that, and thus may be inadequate to motivate adaptive
planning. By periodically scanning a patient with a DECT protocol, the clinician can expect a much larger
treatment response signal in the MEI (see Figs. 4 and 5). For the 10 patients in our study the average reduction

in CT number was 1 HU in the 40 keV MEI and 4 HU in the 120 kVp PEI. As a consequence, adaptive replanning
would be indicated sooner for appropriate patients.

5 Conclusions
Radiation therapy planning and delivery can be improved by using DECT. Low‐energy monoenergetic images
from DECT can enhance soft tissue contrast relative to standard CT as demonstrated in this study. For all patient
data analyzed, DECT substantially increased the difference in CTN between the pancreas head and duodenum.
Furthermore, MEI/DECT amplified the changes in CT textures during radiation delivery, potentially allowing an
earlier detection of treatment response. The use of monoenergetic 40 keV MEI from DECT enhanced the
radiation‐induced change in the mean CTN in the target by a factor of 2–3 compared to what was measured
with standard CT for the pancreatic cancer patients studied. The amplifications of entropy from MEI vs PEI are
up to a factor of 5 for the selected patients.
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